DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Amanta Healthcare Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 3 hrs ago·6 Oct 2026, 11:59 am

Amanta Healthcare

Amanta Healthcare Limited has informed stock exchanges that it has obtained a certificate under SEBI (Depositories and Participants) Regulations, 2018. This document confirms that the company has complied with the necessary regulations regarding its securities depository operations.

For investors, this is a standard procedural update. It signifies that Amanta has fulfilled its regulatory obligations related to the dematerialization and settlement of shares, ensuring the company's shares are eligible for trading in the demat form. This compliance is a prerequisite for maintaining a healthy trading environment for the stock.

Investors should view this as a routine administrative milestone rather than a market-moving event. However, keeping an eye on the company's future regulatory filings will help ensure ongoing compliance with SEBI rules.